Table 1.
Demographic and clinical data for patients who donated intestinal samples analyzed in the study
Sample typeGenderTissueAge (yr)DiagnosisIBD medication
Healthy (non-IBD) samples 
Resections Male Colon 73 Sigmoid colon cancer N/A 
Male Colon 73 Concurrent bladder and rectal cancer N/A 
Female Colon 74 Sigmoid adenocarcinoma N/A 
Male Colon 75 Colorectal cancer with liver metastases N/A 
Female Colon 63 Caecal tumor and bladder tumor N/A 
Female Colon 73 Adenocarcinoma N/A 
Male Colon 64 Adenocarcinoma N/A 
Male Colon 64 Adenocarcinoma N/A 
Female Colon 51 Colon cancer with metastases N/A 
Male Colon 40 Rectal carcinoma with metastases N/A 
Male Rectum 67 Rectal carcinoma N/A 
Female Colon 57 Colon cancer with metastases N/A 
Female Colon 61 Colonic polyp N/A 
Biopsies Male Colon 46 Healthy (screen for cancer) N/A 
Female Colon 61 Healthy (screen for cancer) N/A 
Male Colon 79 Healthy (screen for cancer) N/A 
IBD patients 
Resections Female Colon 31 Active Crohn’s disease Azathioprine 
Female Colon 21 Active Crohn’s disease Vedolizumab, prednisolone 
Male Colon 25 Active Crohn’s disease Infliximab, methotrexate 
Female Colon 47 Active Crohn's disease Prednisolone, simethicone 
Female Colon 59 Active Crohn’s disease Azathioprine, adalimumab, methotrexate 
Male Colon 51 Active ulcerative colitis Adalimumab 
Male Colon 25 Active ulcerative colitis Azathioprine, mesalazine 
Biopsies Male Rectum 25 Active Crohn’s disease Adalimumab, methotrexate 
Female Colon 23 Active Crohn’s disease Infliximab 
Male Rectum 17 Active ulcerative colitis Infliximab 
Male Rectum 57 Active ulcerative colitis Prednisone, omeprazole, mesalazine 
Sample typeGenderTissueAge (yr)DiagnosisIBD medication
Healthy (non-IBD) samples 
Resections Male Colon 73 Sigmoid colon cancer N/A 
Male Colon 73 Concurrent bladder and rectal cancer N/A 
Female Colon 74 Sigmoid adenocarcinoma N/A 
Male Colon 75 Colorectal cancer with liver metastases N/A 
Female Colon 63 Caecal tumor and bladder tumor N/A 
Female Colon 73 Adenocarcinoma N/A 
Male Colon 64 Adenocarcinoma N/A 
Male Colon 64 Adenocarcinoma N/A 
Female Colon 51 Colon cancer with metastases N/A 
Male Colon 40 Rectal carcinoma with metastases N/A 
Male Rectum 67 Rectal carcinoma N/A 
Female Colon 57 Colon cancer with metastases N/A 
Female Colon 61 Colonic polyp N/A 
Biopsies Male Colon 46 Healthy (screen for cancer) N/A 
Female Colon 61 Healthy (screen for cancer) N/A 
Male Colon 79 Healthy (screen for cancer) N/A 
IBD patients 
Resections Female Colon 31 Active Crohn’s disease Azathioprine 
Female Colon 21 Active Crohn’s disease Vedolizumab, prednisolone 
Male Colon 25 Active Crohn’s disease Infliximab, methotrexate 
Female Colon 47 Active Crohn's disease Prednisolone, simethicone 
Female Colon 59 Active Crohn’s disease Azathioprine, adalimumab, methotrexate 
Male Colon 51 Active ulcerative colitis Adalimumab 
Male Colon 25 Active ulcerative colitis Azathioprine, mesalazine 
Biopsies Male Rectum 25 Active Crohn’s disease Adalimumab, methotrexate 
Female Colon 23 Active Crohn’s disease Infliximab 
Male Rectum 17 Active ulcerative colitis Infliximab 
Male Rectum 57 Active ulcerative colitis Prednisone, omeprazole, mesalazine 

N/A, not applicable.

[ViewLarge]
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal